01332 TOUYUN BIOTECH
- 0.194
- +0.001+0.52%
TOUYUN BIOTECH News
China Touyun Tech Widens Loss in 2023 Amid Lower Sales Orders
China Touyun Tech Group (HKG:1332) recorded an increase in attributable loss for 2023 to HK$268.9 million, from HK$198.1 million yuan a year ago, according to the company's annual report posted on the
透雲生物：2023年年報
Touyun Biotech (01332) released annual results, losses attributable to shareholders of 269 million yuan, an increase of 35.78% year-on-year
According to the Zhitong Finance App, Touyun Biotech (01332) announced its annual results for the year ended December 31, 2023. The group achieved gross profit of HK$55.99 million during the period, a year-on-year decrease of 56.13%; shareholders' losses of 269 million yuan, an increase of 35.78% over the previous year; and a basic loss of 9.58 HK cents per share. According to the announcement, for the year ended 31 December 2023, the Group obtained revenue of approximately HK$198.6 million (2022: HK$315.8 million), a decrease of approximately 37.1% compared to last year. The decrease in turnover was mainly due to a decrease in sales orders for packaged products.
TOUYUN BIOTECH: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Touyun Biotech (01332.HK) held a board meeting on March 28 to approve publication of annual results
Gelonghui, March 14, 丨 Touyun Biotech (01332.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to approve (among other things) the publication of the annual results announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the payment of a final dividend.
TOUYUN BIOTECH: INTERIM REPORT 2023
Touyun Biotech (01332) Announces Interim Results, Shareholders' Share of Loss of HK$83.951 million narrowed 4.67% year-on-year
Touyun Biotech (01332) announced its interim results for the six months ended June 30, 2023. The group collected during the period...
TOUYUN BIOTECH: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
Tuyun Biotech (01332.HK) will hold a board meeting on August 25 to approve the interim results
On August 11, GLONGWI | TOYUNBIO (01332.HK) announced that the company will hold a board meeting on August 25, 2023 to approve the publication of the company and its subsidiaries's interim results announcements for the six months ended June 30, 2023, and consider the payment of interim dividends.
TOUYUN BIOTECH: DATE OF BOARD MEETING
Tian Uzawa sold 220,000 common shares of Touyun Biotech (01332.HK) worth approximately HK$114,400
According to reports on June 8, according to documents disclosed by the Hong Kong Stock Exchange on June 8, Tian Yuze sold $220,000 common shares of Tooyun Biotech (01332.HK) at an average price of HK$0.502 per share on June 6, worth about HK$114,400. After the sale, Tian Yuze recently held 148 million shares, with a good position ratio of 5.26%. The transaction involved another related party: Tauze. Photo Source: Stock Exchange's equity disclosure (partial table of this incident) What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their listed shares
Tian Yuze sold 120,000 common shares of Touyun Biotech (01332.HK) worth approximately HK$63,800
According to reports on June 5, according to documents disclosed by the Hong Kong Stock Exchange on June 5, Tian Yuze sold $120,000 common shares of Tooyun Biotech (01332.HK) at an average price of HK$0.532 per share on May 29, worth about HK$63,800. After the sale, the latest number of shares held by Tian Yuze was 148 million shares, and the ratio of good positions dropped from 5.27% to 5.26%. The transaction involved another related party: Tauze. Photo Source: Stock Exchange's equity disclosure (partial table of this incident) What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) must
Touyun Biotech: 2022 Annual Report
Touyun Biotech: Annual Results Announcement for the Year Ended December 31, 2022
Touyun Biotech (01332.HK) plans to hold board review and approval of annual results on March 27
Gelonhui, March 13, 丨 Tooyun Biotech (01332.HK) announced that the company will hold a board meeting on March 27, 2023 (Monday) to (among others) approve the publication of the company and its subsidiaries' annual results announcements for the year ended December 31, 2022, and consider the payment of a final dividend.
Cloud-penetrating organisms: interim report 2022
Cloud Biology: interim results for the six months ended June 30, 2022
Tuyun Biotech (01332.HK) will hold a board meeting on August 26 to approve the interim results
GLONGHUI August 16 | TOYUNBIO (01332.HK) announced that the company will hold a board meeting on August 26, 2022 to approve the publication of the company and its subsidiaries's interim results announcements for the six months ended June 30, 2022, and to consider the payment of interim dividends.
01332.HK: Li Anle is appointed as secretary
Gelonghui, August 1 (01332.HK) announcement, Huang Yaxin has resigned as company secretary, effective August 2, 2022. Anle Li has been appointed as the company secretary with effect from August 2, 2022.
Tuoyun Biology (01332): Li Anle was appointed Company Secretary
Zhitong Financial APP News, Touyun Bio (01332) issued an announcement that Huang Yaxin has submitted his resignation as company secretary, effective from August 2, 2022. In addition, Li Anle has been appointed as the company secretary with effect from August 2, 2022.
Analysis
Price Target
No Data
